Despite the importance of somatodendritic dopamine (DA) release in the Substantia Nigra pars compacta (SNc), its mechanism remains poorly understood. Using a novel approach combining fast-scan controlled-adsorption voltammetry (FSCAV) and single-unit electrophysiology, we have investigated the mechanism of somatodendritic release by directly correlating basal (non-stimulated) extracellular DA concentration ([DA] out ), with pharmacologically-induced changes of firing of nigral dopaminergic neurons in rat brain slices. FSCAV measurements indicated that basal [DA] out in the SNc was 40.7 AE 2.0 nM (at 34 AE 0.5°C), which was enhanced by amphetamine, cocaine, and L-DOPA, and reduced by VMAT2 inhibitor, Ro4-1284 
It has long been established that dopaminergic neurons of the Substantia Nigra pars compacta (SNc) not only release dopamine (DA) from striatal axon terminals, but also from their somata and dendrites (Geffen et al. 1976 ). Yet despite the importance of somatodendritic release for auto-regulation of SNc neurons (Ford 2014 ) and modulation of basal ganglia output (Radnikow and Misgeld 1998; Zhou et al. 2009 ), the mechanisms underlying somatodendritic DA release are not fully understood (Rice and Patel 2015; Gantz et al. 2018) . Nigral dopaminergic neurons are spontaneously active, firing regular or bursts of action potentials in vivo (Chiodo 1988) , and display pacemaker-like firing in brain slices (Grace and Onn 1989) . However, while firing evokes 'classical' vesicular release of DA from axon terminals, the relationship between electrophysiological activity and somatodendritic release remains unclear.
Mechanisms of somatodendritic DA release have predominantly been studied in brain slices because of the difficulty of distinguishing between local and afferent modulation of release in vivo (Rice and Patel 2015) . Previous electrochemical and electrophysiological studies have indicated that stimulated somatodendritic release depends on both intracellular and extracellular sources of Ca 2+ Chen and Rice 2001) , vesicular monoamine transporter-2 (VMAT2)-dependent DA stores (Beckstead et al. 2004) , and voltage-gated Na + channels Beckstead et al. 2004 ). These observations suggest that release occurs by action potential-dependent exocytosis. However, a major limitation of these studies is that DA release was artificially evoked by electrical stimulation. Bursts or even single electrical pulses can deplete releasable pools of DA, since repeated stimuli cannot evoke reproducible DA spillover, even after prolonged intervals Chen et al. 2011) . Furthermore, electrical stimulation with large stimulating currents can evoke nonphysiological DA release by direct activation of voltagegated Ca 2+ channels . Finally, serotonergic terminals may contribute to DA release in the SNc after electrical stimulation (Gantz et al. 2015) .
In contrast, spontaneous (non-stimulated) somatodendritic DA release is less dependent on voltage-gated Na + channels than electrically evoked release. Spontaneous D 2 receptormediated inhibitory post-synaptic currents (D 2 -IPSCs) are unaffected by blocking voltage-gated Na + channels (Gantz et al. 2013) , while the frequency of quantal events measured with amperometry is only halved (Kim et al. 2008) . These observations are in contrast to the strong dependence of both action potential firing (Guatteo et al. 2013 ) and stimulated DA release on voltage-gated Na + channels Beckstead et al. 2004) . Furthermore, spontaneous somatodendritic release persists in zero extracellular Ca 2+ (Kim et al. 2008; Gantz et al. 2013) , and relatively few DA vesicles occupy the somata and dendrites of SNc neurons (Nirenberg et al. 1996) which lack typical isoforms of vesicle docking proteins ). These observations suggest that spontaneous somatodendritic DA release does not critically depend on classical action potential-dependent exocytosis. Despite this, no studies have directly correlated spontaneous somatodendritic DA release with electrophysiological activity of SNc neurons.
Unlike other spontaneously active neurons, nigral dopaminergic neurons engage L-type Ca 2+ channels during pacemaking (Nedergaard et al. 1993; Guzman et al. 2009; Ortner et al. 2017) . Subthreshold activation of these channels not only predisposes SNc neurons to damage (Guzman et al. 2010) , but also may provide a mechanism for Ca 2+ -dependent, spontaneous somatodendritic DA release, independent of action potentials (Cobb and Abercrombie 2003) . This is consistent with action potential-independent, dendritic release of serotonin (5-HT) mediated by L-type Ca 2+ channels in dorsal raphe neurons (Colgan et al. 2012) . Expression of the same L-type Ca 2+ channels suggests that somatodendritic DA release may share similar mechanisms. However, there is no consensus on the involvement of specific Ca 2+ channels in somatodendritic release (Chen et al. 2006; Kim et al. 2008; Mendez et al. 2011) . Additionally, the importance of intracellular Ca 2+ stores for release also remains under dispute Gantz et al. 2013) .
The aim of this study was to further investigate the mechanism of somatodendritc DA release. Using a novel approach combining extracellular electrophysiology and fastscan controlled-adsorption voltammetry (FSCAV; Atcherley et al. 2013; Burrell et al. 2015; Atcherley et al. 2015) , we have examined the relationship between tonic (non-stimulated) somatodendritic DA release and the spontaneous firing of nigral dopaminergic neurons in rat midbrain slices. FSCAV exploits the adsorption kinetics of DA to a carbon sensor, allowing highly sensitive, prolonged measurement of absolute extracellular DA concentration ([DA] out ), which we have directly correlated with drug-induced changes of neuronal firing. Our results provide additional evidence that tonic somatodendritic DA release is largely independent of action potentials. Furthermore, we show that this process requires releasable DA stores and is regulated by changes of membrane potential and both intracellular and extracellular sources of Ca 2+ .
Materials and methods
All experimental procedures were approved by the Animal Ethics Committee of the University of Auckland (AEC 001049 and 001748), in accordance with the New Zealand Government Animal Welfare Act. This study was not pre-registered. Horizontal midbrain slices (300 lm) were obtained from male or female P21-23 Wistar rats (RRID: RGD_13508588), housed in a humidity and temperature (20 AE 1°C) controlled environment with reversed 12/12 h light/dark cycle and access to food and water ad libitum. The brain was rapidly removed after brief CO 2 or isoflurane anesthesia (MedSource, catalogue no.: vapdrugiso; fast-acting anesthetics commonly used for brain slice preparation, e.g. Guatteo et al. 2013; Melchior et al. 2015) and a midbrain tissue block containing the SNc was sectioned by vibratome (VT1200S, Leica), while submerged in cold (5-8°C), carbogenated (5% CO 2 in O 2 ) artificial cerebrospinal fluid (aCSF) containing (mM): 127 NaCl, 3 KCl, 2 CaCl 2 , 1.25 NaH 2 PO 4 , 2 MgSO 4 , 10 glucose, 26 NaHCO 3 (290 mOsm/L, pH 7.4). Slices were allowed to equilibrate and maintained at 34°C in a custom-built incubation chamber before being individually transferred to a recording chamber (Warner Instr.; volume~1 mL) superfused (3.5 mL/min) with carbogenated aCSF for the duration of experiments (34 AE 0.5°C).
Fast-scan controlled-adsorption voltammetry (FSCAV)
Cylindrical carbon fiber microelectrodes (CFMs) were manufactured as described previously (Burrell et al. 2015) . Briefly, a carbon fiber (diameter 7 lm; Goodfellow Cambridge Ltd., cat.: C005722) was threaded through a pulled glass pipette after breaking the tip to a diameter of 10-15 lm. The tip was sealed and electrically insulated by back injection of epoxylite resin (Elantas PDG, cat.: 48-1696), followed by injection of a carbon-based wire glue (Anders Products, cat.: 0400) to attach a copper wire soldered to a gold-plated terminal. The exposed portion of the carbon fiber was trimmed to a length of 50-80 lm. For in vivo experiments, CFMs were coated with poly (3,4-ethylenedioxythiophene (PEDOT; 400 lM; Sigma-Aldrich, St. Louis, Missouri, U.S.A. cat.: 483028) and Nafion (0.05%; dissolved in acetonitrile; Sigma-Aldrich, cat.: 70160) to improve selectivity and sensitivity for detection of DA (Vreeland et al. 2015) . For brain slice experiments, the tip of the CFM was positioned in the SNc, visually identified as a densely packed group of cells adjacent to the medial terminal nucleus of the accessory optic tract, 150 lm below the surface of the slice (Fig. 1a) . FSCAV was conducted using WCCV software (v.3.0, Knowmad Technologies) interfaced with a DAC/ADC card (PCIe-6321; National Instr.) and a potentiostat (Chem-Clamp, Dagan Corp.; Atcherley et al. 2013 Atcherley et al. , 2015 Burrell et al. 2015) . Voltage commands applied to the CFM were alternated between triangular waveform scanning (À0.4 to +1.3 V; 1200 V/s) at 100 Hz (10 s) and a constant DC potential ('pause'; À0.3 V, 10 s). This pause in scanning allowed adsorption of DA to the CFM surface and full equilibration with the extracellular milieu. When scanning was resumed, DA concentration was measured by integrating faradaic currents generated by its oxidation (see below). Further scanning minimized DA adsorption to the CFM before the next measurement period (20 s). Voltage commands were controlled by a high-speed CMOS analog switch (ADG419, Analogue Devices) gated by a TTL pulse (Fig. 1a) . Recordings were commenced after a period of electrode stabilization which was monitored online using custom software (Live Electrochemistry, P. S. Freestone).
CFMs were calibrated before and after experiments in a beaker containing Tris-buffered aCSF (NaHCO 3 replaced by 10 mM Trisbase; pH 7.4; Sigma-Aldrich, cat.: T1503). Calibration curves were constructed by adding aliquots of concentrated DA stock (100 lM) in 20-100 nM steps. A quadratic model was fitted to the integral of faradaic currents (limits: +0.4 to +0.9 V) generated from the 10th scan after each pause. This scan was chosen because of its high selectivity for DA over its metabolites and other electrochemically active species (Atcherley et al. 2013; Burrell et al. 2015) . Multiple calibrations were conducted at 24 and 34°C, and in different Ca 2+ concentrations ('zero', 1, 2, and 5 mM CaCl 2 ). The DA sensitivity of FSCAV was temperature-dependent (24.9 AE 0.1% greater charge for 500 nM of DA at 24 vs. 34°C; data not shown), presumably because of weaker desorption of DA during the pause (compared to voltage-driven DA adsorption) at the lower temperature. Furthermore, DA sensitivity was also 
Electrophysiology
The spontaneous firing of nigral dopaminergic neurons was measured during each pause of CFM scanning (while the CFM was held at À0.3 V), using conventional extracellular glass microelectrodes (5-10 MO) and an AC amplifier (NL104, Neurolog; 0.05-5 kHz) as described previously (Yee et al. 2017) . To avoid interference caused by ground loops during electrochemical measurements, the shared reference electrode (Ag/AgCl) was disconnected from the AC headstage during CFM scanning using an additional CMOS switch controlled by the same TTL pulse used to alternate between voltage commands for FSCAV (Fig. 1a) . , pH 7.3). Nigral dopaminergic neurons were identified as medium sized (diameter ≥ 20 lm), densely packed cells, which displayed depolarizing sag in response to hyperpolarizing current steps (À100 to À300 pA, 500 ms) and spike frequency adaptation in response to depolarizing steps (50-150 pA, 500 ms).
Electrophysiological data were analyzed in Clampfit (v.10.2; Molecular Devices). Firing rate was calculated by averaging instantaneous frequencies generated by threshold search of electrophysiological recordings during each pause of scanning. In currentclamp recordings, membrane potential was measured just prior to slow depolarizations (pacemaker potentials) preceding action potentials (Guatteo et al. 2013) .
Measurement of intracellular Ca

2+
Changes of cytosolic free Ca 2+ concentration ([Ca 2+ ] in ) were measured using fura-2, directly loaded to neurons through the patch pipette (fura-2 pentapotassium salt; 250 lM; Invitrogen, cat.: F1200), or bolus-loaded (from external glass pipette, tip diameter: 2 lm; positive pressure: 5 p.s.i., 10 min) to avoid significant disruption of endogenous Ca 2+ buffering (fura-2 acetoxymethyl (AM) ester; 10 lM; Molecular Probes, cat.: F1201). Excitation wavelengths (340/380 nm) were provided by a xenon lamp (175 W; Sutter Instr.) through a filter wheel (Optospin; Cairn Research). Fluorescence images were captured using a 12-bit cooled CCD camera (ORCA-ER; Hamamatsu). Background subtracted fluorescence ratios were analyzed using Imaging Workbench (v.5.2; Indec Biosystems) and converted to [Ca 2+ ] in using a standard procedure (Grynkiewicz et al. 1985) .
In vivo FSCAV and electrophysiology Male Wistar rats (290-330 g) were anesthetized with urethane (1.6 g/kg, i.p.; Sigma-Aldrich, cat.: U2500; providing stable, longlasting anesthesia with little effect on DA signaling, e.g., Sabeti et al. 2003; Atcherley et al. 2015) and a cannula was inserted into a femoral vein for systemic drug application. Rats were placed in a stereotaxic frame (Model 940; Kopf) and bilateral craniotomies were performed over the striatum and Substantia Nigra after subcutaneous marcain anesthesia (0.125 mg/kg; AstraZeneca, cat.: PHX241). A bipolar stimulating electrode was positioned in the dorsal striatum (bregma: AP: À0.3 mm, ML: 3.3 mm, DV: À4.2 mm) for antidromic stimulation of nigrostriatal neurons. An Ag/AgCl reference electrode was implanted subcutaneously at the base of the neck. FSCAV and electrophysiological measurements were conducted using a single CFM slowly lowered to the depth of the SNc (bregma: AP: À5.4 mm, ML: 2.0 mm, DV: À7.5 to À8.5 mm). Electrophysiological activity was monitored while descending and [DA] out was measured every 0.5 mm by changing connection between AC amplifier and FSCAV headstages. The SNc was identified by electrophysiological measurement of longduration, biphasic (positive-negative), spontaneous action potentials, and antidromically activated spikes (Fig. 7a ). Animals were maintained at 36 AE 0.5°C and heart rate (400-450/min), O 2 saturation (~99%), and respiratory rate (~100/min) were continuously monitored. At the end of experiments, animals were sacrificed by urethane overdose.
Drugs and reagents
Unless otherwise specified, all chemicals and reagents were purchased from Sigma-Aldrich. over a 1 min period at the end of drug application and compared to a pre-treatment baseline period (1 min). Sample sizes were not predetermined, but experimental groups included slices obtained from a minimum of two different animals. Randomization and blinding were not required since brain slices were prepared, and in vivo recordings were conducted using experimentally na€ ıve animals. No animals were excluded from analyses. Statistical analyses were conducted in Statistica (v.8.0, StatSoft) using paired (dependent) samples Student's t-test, or by repeated measures analysis of variance (rm-ANOVA) followed by planned (a priori) comparisons. Normality was tested using Shapiro-Wilk's (S-W) test and homogeneity of variance or sphericity were tested using Levene's or Mauchley's tests, respectively. If these assumptions were violated (S-W statistics reported in text), an equivalent non-parametric test (Wilcoxon signed rank) was performed. Data are presented as mean AE SEM (median effect reported in text for non-parametric analyses). In figures, '*', '**', '***' and '#', '##', '###' denote statistical significance of p < 0.05, p < 0.01, p < 0.001 for dependent and independent measures, respectively. Exact p-values are reported in text.
Results
Measurement of basal [DA] out with FSCAV
For the first time, we have used FSCAV to measure absolute extracellular DA concentration ([DA] out ) in the SNc of rat midbrain slices (Fig. 1) . These measurements demonstrated a basal FSCAV signal with oxidation and reduction peaks at +0.71 AE 0.00 V and À0.19 AE 0.01 V, respectively, (n = 10 slices from 6 animals; Fig. 1b color plot), consistent with the electrochemical profile of DA (Fig. 1c) . Integration of the peak oxidation current (between +0.4 and +0.9 V) produced an average charge of 0.71 AE 0.08 pC (at 34.0 AE 0.5°C), corresponding to basal [DA] out in the slice (Fig. 1c) . Simultaneous electrophysiological recordings with glass microelectrodes near the CFM (< 100 lm) indicated that FSCAV measurements were among the somata of spontaneously active neurons (e.g., Fig. 1b) . Spontaneous firing was slow (2.08 AE 0.14 Hz; n = 9 units from 6 animals) and regular (coefficient of variation: 3.0 AE 0.4%), with long-duration (1.74 AE 0.06 ms), biphasic (positive-negative) action potentials, often with a characteristic 'notch' in the rising phase (initial segment-somatodendritic delay; Fig. 1a inset arrowhead). These features were consistent with electrophysiological properties of nigral dopaminergic neurons (Grace and Onn 1989) , confirming that FSCAV measurements were within the SNc region. Lowering bath temperature by 10°C not only reduced neuronal firing rate (24°C: 0.74 AE 0.21 Hz; t (8) =11.30, p = 3.4 9 10 À6 , paired t-test; data not shown), but also decreased the FSCAV signal to 0.27 AE 0.04 pC (t (9) =8.89, p = 9.4 9 10 À6 , paired t-test; Fig. 1c ). We inferred that this residual signal was generated by oxidation of DA which had lastingly adsorbed to the CFM, rather than being sampled from the slice, since lowering temperature by 10°C almost completely (> 90%) abolishes spontaneous quantal DA release (Jaffe et al. 1998) . Therefore, this value was interpreted as 'zero' [DA] out , and the FSCAV signal measured at 24°C was subtracted from recordings at 34°C, after conversion of charge (pC) to DA concentration (nM) using calibrations performed in beaker. This resulted in an average basal extracellular DA concentration of 40.7 AE 2.0 nM (n = 96 slices obtained from 51 animals) in the SNc (average of all subsequent measurements).
Pharmacological validation of FSCAV measurements
The identity of the FSCAV signal in the SNc was verified pharmacologically using drugs known to increase or decrease DA release (Fig. 2) . Amphetamine (10 lM, 20 min) increased basal [DA] out by 91.4 AE 17.6 nM (n = 6 from 3 animals; F (1,5) =26.88, p = 0.004, rm-ANOVA; Fig. 2a and c) . Subtraction of voltammograms before (i) and after (ii) amphetamine exposure revealed oxidation and reduction peaks at +0.72 AE 0.01 V and -0.21 AE 0.02 V, respectively, indicating that amphetamine evoked a specific rise of [DA] out (Fig. 2b) . Cocaine (10 lM) reduced amphetamine-induced release by 27.5 AE 2.3% (F (1,5) =9.04, p = 0.03, rm-ANOVA), confirming that amphetamine releases DA at least partly by reversal of the dopamine transporter (DAT; Fig. 2a ). Amphetamine-induced DA release slowed neuronal firing (from 2.10 AE 0. Inhibition of DAT by cocaine (10 lM, 20 min) on its own, increased basal [DA] out by 6.8 AE 2.9 nM (n = 13 from 6 animals; S-W: W = 0.81, p = 0.008; median D [DA] out = 3.5 nM; Z = 2.20, p = 0.03, Wilcoxon signedrank test; Fig. 2c ) and decreased neuronal firing (from 2.16 AE 0.16 Hz to 1.69 AE 0.22 Hz; n = 12 from 6 animals; t (11) =3.25, p = 0.008, paired t-test; data not shown). In contrast to amphetamine-induced release (Fig. 2a) , this indicated that spontaneous somatodendritic DA release was not mediated by reversal of DAT.
Next, we tested the effect of Ro4-1284, a fast-acting, reserpine-like substance which depletes DA stores by inhibiting vesicular monoamine transporter-2 (VMAT2; Fig. 2c ). Prolonged exposure to Ro4-1284 (10 lM, 60 min) decreased basal [DA] out by 12.7 AE 4.2 nM (-29.8 AE 6.5%; n = 6 from 5 animals; t (5) =2.98, p = 0.03, paired t-test) but had no effect on neuronal firing rate (data not shown). This suggested that tonic somatodendritic release was in part dependent on DA stores.
Tonic somatodendritic release is largely independent of neuronal firing rate Action potential-dependence of spontaneous somatodendritic DA release was investigated by inhibiting voltage-gated Na + channels with tetrodotoxin (TTX; Fig. 3 ). Application of TTX (0.5 lM, 5 min) quickly abolished neuronal firing (DHz = À2.25 AE 0.21 Hz; n = 12 from 7 animals; t (11) =10.65, p = 3.9 9 10 -7 , paired t-test), but only evoked a small, yet consistent decrease in basal [DA] out (À2.0 AE 0.4 nM; À6.6 AE 1.7%; n = 12 from 7 animals; t (11) =5.01, p = 4.0 9 10 À4 , paired t-test; Fig. 3b ). Although this effect was small, a specific decrease in faradaic current at the oxidation potential for DA was evident in expanded voltammograms (Fig. 3c ).
To determine whether the effect of TTX was larger when [DA] out and firing rate were elevated, we applied TTX after pre-treatment of slices with monoamine oxidase (MAO) inhibitor, pargyline, DA precursor, L-DOPA, and D 2 receptor antagonist, raclopride (Fig. 3d) . In the presence of pargyline (10 lM), L-DOPA (50 lM, 10 min) increased [DA] out by 317.9 AE 26.4 nM (n = 8 from four animals; F( 1,7) = 165.92, p = 3.9 9 10 À6 , rm-ANOVA) and decreased neuronal firing rate (from 1.97 AE 0. . We tested whether D 2 receptors also regulate non-stimulated (tonic) release using D 2 receptor agonist, quinpirole (Fig. 4) . Similar to the effect of TTX, quinpirole quickly abolished the firing of nigral dopaminergic neurons (DHz = -1.82 AE 0.13 Hz; n = 14 from 8 animals; t (13) =15.26, p = 1.1 9 10
À9
, paired t-test; Fig. 4a and b) . However, activation of D 2 receptors evoked a larger decrease in basal [DA] out (À7.2 AE 1.5 nM; 20.6 AE 4.1%; t (13) =4.90, p = 2.9 9 10 À4 , paired t-test; Fig. 4a ), which was significantly greater than the effect of TTX (F (1,24) = 10.01, p = 0.004, rm-ANOVA; Fig. 4b ). The decrease in [DA] out evoked by quinpirole was independent of neuronal firing since quinpirole (5 lM, 5 min) decreased [DA] out when firing had already been abolished by TTX (À4.2 AE 1.0 nM; À13.2 AE 3.1%; n = 4 from 2 animals; t (3) = 4.17, p = 0.025, paired t-test; Quin vs. Quin + TTX: F (1,16) = 1.12, p = 0.31, rm-ANOVA; Fig. 4b ). This suggested that reduction in [DA] out was because of cell membrane hyperpolarization, as opposed to inhibition of firing. We hypothesized that decreased [DA] out evoked by quinpirole was because of enhanced uptake of DA via DAT, since D 2 -mediated hyperpolarization can drive DAT activity . Since DAT inhibition alone activates D 2 receptors (through extracellular accumulation of DA), we used GABA B receptor agonist baclofen to hyperpolarize neurons while blocking DAT with cocaine and D 2 receptors with raclopride. On its own, baclofen (3 lM; 5 min) inhibited firing from 2.28 AE 0.12 Hz to 1.17 AE 0.32 Hz (n = 5 from four animals; t (4) =2.86, p = 0.046, paired t-test), and decreased basal [DA] out by 2.2 AE 0.7 nM (-8.4 AE 2.6%; n = 8 from 5 animals; t (7) =3.38, p = 0.01, paired t-test; Fig. 4b ). However, contrary to our hypothesis, inhibiting DAT with cocaine (10 lM; and D 2 receptors with raclopride, 1 lM) did not significantly reduce the effect of baclofen on somatodendritic release (-2.0 AE 0.2 nM; -5.0 AE 1.3%; n = 5 from three animals; Bac vs. Bac + Coc + Rac: F (1,11) =0.09, p = 0.77, rm-ANOVA; Fig. 4b (Guatteo et al. 2004) . As expected, quinpirole (5 lM, 5 min) inhibited neuronal firing (DHz = À1.95 AE 0.46 Hz; n = 5 from three animals) by hyperpolarizing cell membrane potential (DV m = À11.83 AE 1.33 mV), and decreased [Ca 2+ ] in by 108.8 AE 39.4 nM ( Fig. 5a and c) . In contrast, although TTX (0.5 lM, 5 min) also abolished firing (DHz = -1.64 AE 0.44 Hz; n = 6 from 5 animals), inhibition of voltage-gated Na + channels did not hyperpolarize SNc neurons (DV m = 2.17 AE 2.63 mV) and evoked significantly smaller reduction in [Ca 2+ ] in (D[Ca 2+ ] in = -26.1 AE 6.1 nM; Quin vs. TTX: F (1,9) =6.82, p = 0.03, rm-ANOVA; Fig. 5b and  c) . Instead, slow oscillatory potentials (SOPs) were revealed in the absence of action potentials after TTX (Fig. 5b inset) . The effects of quinpirole and TTX on [Ca 2+ ] in were confirmed using fura-2 AM to avoid cell dialysis-related changes of intracellular Ca 2+ buffering. After bolus-loading neurons with this membrane-permeable Ca 2+ sensor, quinpirole (5 lM, 5 min) decreased [Ca 2+ ] in by 9.1 AE 2.1% (n = 5 from two animals) while TTX (1 lM, 5 min) had little effect (D [Ca 2+ ] in = -1.6 AE 1.4%; n = 7 from four animals; Quin vs. TTX: F (1,10) = 7.40, p = 0.02, rm-ANOVA; data not shown). These changes of [Ca 2+ ] in were consistent with the smaller decrease in [DA] out evoked by TTX compared to quinpirole, despite similar effects on spontaneous firing.
The inability of spontaneous firing frequency to predict basal [DA] out was illustrated by regression analysis which demonstrated the lack of a relationship between baseline measurements of firing rate and basal [DA] out (n = 96 from 51 animals; adjusted R 2 =À0.02, F (2,78) = 0.40, p = 0.67, multiple regression; Fig. 5d firing rate evoked by TTX (0.5 lM, n = 12 slices, n = 12 units), quinpirole (Quin; 5 lM, n = 14 slices, n = 14 units), quinpirole (5 lM) in the presence of TTX (0.5 lM, n = 4 slices), baclofen (Bac; 3 lM, n = 8 slices, n = 5 units), and baclofen (3 lM) in the presence of cocaine (Coc; 10 lM) and raclopride (Rac; 1 lM, n = 5 slices, n = 7 units). Note no change in firing (ncf) evoked by quinpirole in TTX since firing was already abolished by TTX. *p < 0.05, **p < 0.01, ***p < 0.001, ## p < 0.01.
regression; Fig. 5e Additionally, inhibition of L-type Ca 2+ channels with nifedipine (10 lM, 20 min) decreased basal [DA] out by 6.9 AE 2.1 nM (À15.9 AE 6.7%; n = 12 from six animals; t (11) = 3.26, p = 0.008, paired t-test; Fig. 6a ) and slowed neuronal firing from 1.81 AE 0.11 Hz to 1.04 AE 0.21 Hz (t (11) = 3.58, p = 0.004, paired t-test). In comparison, specific inhibition of Ca v 1.3 L-type Ca 2+ channels by isradipine (30 nM, 30 min) had no effect on firing frequency (baseline: 2.35 AE 0.37 Hz, isradipine: 2.29 AE 0.36 Hz; n = 11 from four animals; t (10) =1.05, p = 0.32, paired t-test; Fig. 6a ), but significantly decreased basal [DA] out by 6.1 AE 2.1 nM (À20.9 AE 9.3%; n = 7 from four animals; t (6) =2.92, p = 0.03). Although the effect of isradipine on firing was significantly smaller than the effect of nifedipine (isradipine vs. nifedipine: F (1,21) =9.12, p = 0.007, rm-ANOVA), specific inhibition of Ca v 1.3 channels produced a similar decrease in [DA] out (F (1,17) =0.06, p = 0.81, rm-ANOVA). This demonstrated the importance of Ca 2+ influx via Ca v 1.3 channels, rather than inhibition of action potentials, for regulation of tonic somatodendritic DA release.
Importantly, depletion of intracellular Ca 2+ stores with sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase (SERCA) inhibitor, cyclopiazonic acid, caused an even larger reduction in [DA] out (Fig. 6b) . cyclopiazonic acid (30 lM, 30 min) decreased basal [DA] out by 39.4 AE 8.6 nM (À69.2 AE 9.0%; n = 6 from 2 animals; S-W: W = 0.68, p = 0.003; median D[DA] out = À27.8 nM; Z = 2.20, p = 0.028, Wilcoxon signed-rank test) and slowed firing from 2.03 AE 0.23 Hz to 1.71 AE 0.25 Hz (n = 7 from three animals; t (6) =2.93, p = 0.026, paired t-test). These data suggested that tonic somatodendritc release strongly depends on intracellular Ca 2+ stores.
FSVAV measurement of basal [DA] out in the SNc in vivo FSCAV measurements of [DA] out were also conducted in urethane-anethestized rats using a single PEDOT/Nafioncoated CFM for both electrochemical and electrophysiological recordings (Fig. 7) . The CFM was slowly lowered to the depth of the SNc (DV: À7.5 to À8.5 mm) which was identified by electrophysiological measurement of spontaneous neuronal activity. Dopaminergic SNc neurons fired long-duration (1.28 AE 0.07 ms; n = 10 from 8 animals), biphasic (positive-negative) action potentials, which were more frequent (4.43 AE 0.31 Hz) and less regular (CV: 33.5 AE 6.0%) than those recorded in brain slices. These action potentials often displayed a prominent initial segment-somatodendritic delay ( Fig. 7b inset arrowhead) , similar to brain slices recordings (cf. Fig. 1a inset) . Spontaneous activity was reversibly inhibited by i.v. injection of D 1 /D 2 receptor agonist, apomorphine (0.05-0.1 mg/kg; Fig. 7b ). Striatal projection of these neurons was demonstrated by detection of antidromic spikes evoked by electrical stimulation in the ipsilateral striatum, with latency of 11.64 AE 0.25 ms (Fig. 7a) . These responses were usually smaller than spontaneous action potentials since antidromic spikes often only invade the axon initial segment (Guyenet and Aghajanian 1978) . The antidromic nature of evoked responses was confirmed by collision of antidromic spikes with spontaneous action potentials (Fig. 7a bottom; Lipski 1981) . Together, these data confirmed both the identity of dopaminergic SNc neurons, and position of the CFM among these neurons.
Basal [DA] out was measured every 0.5 mm starting from À6.0 mm below the cortical surface, by switching connection of the CFM between headstages of the AC amplifier and FSCAV potentiostat (Fig. 7a and c) . At the level of the SNc (DV: À7.5 to À8.5 mm), as identified by electrophysiological recordings (see above), integration of peak of firing rate (DHz) evoked by nifedipine (Nif; 10 lM, 20 min; n = 12 slices, n = 12 units) and isradipine (Israd; 30 nM, 30 min; n = 7 slices, n = 11 units). *p < 0.05, **p < 0.01, ## p < 0.01. Inset shows small decrease in current at oxidation peak of DA in voltammograms generated before and at the end of isradipine exposure. (b) Effect of cyclopiazonic acid on basal [DA] out (n = 6 slices) and neuronal firing rate (n = 7 units). *p < 0.05. oxidation current (between +0.4 and +0.9 V) yielded a charge of 1.11 AE 0.12 pC (n = 10 from eight animals; in two rats measurements were made from both hemispheres). This value was significantly higher than the FSCAV signal measured above the level of the SNc (DV: À6.5 mm; 0.58 AE 0.10 pC; t (9) =6.61, p = 9.9 9 10 À5 , paired t-test; Fig. 7c) , and corresponded to basal [DA] out of 79.8 AE 10.9 nM after subtracting the residual signal measured at 24°C in brain slices ('zero' DA release, since this 'offset' was assumed to be a consistent feature of CFMs). Administration of amphetamine (2 mg/kg, i.v.) increased basal [DA] out in the SNc by 24.4 AE 11.3 nM (n = 3 animals), confirming the identity of this signal as DA (Fig. 7d) .
Discussion
FSCAV measurements of basal [DA] out in the SNc
Using a novel electrochemical approach, we have demonstrated that basal [DA] out is approximately 40 nM among spontaneously active SNc neurons in rat midbrain slices. This value was considerably higher than our previous FSCAV measurements of basal [DA] out in striatal slices (< 10 nM), consistent with spontaneous DA release from somata and dendrites of SNc neurons, but minimal tonic release from truncated axon terminals in the striatum (Burrell et al. 2015; Yorgason et al. 2017) . Oxidation and reduction peaks detected with FSCAV in the SNc occurred at potentials expected for DA using conventional fast-scan cyclic voltammetry (FSCV). However, peak oxidation of DA occurred at a more positive potential using FSCAV (around +0.7 V) compared to FSCV (typically +0.6 V). This was attributed to the faster scan rate used in FSCAV (1200 V/s) compared to FSCV (normally 400 V/s; Keithley et al. 2011) . FSCAV measurements of [DA] out were pharmacologically confirmed using amphetamine, which redistributes vesicular DA and promotes its release largely by reverse transport via DAT (Sulzer et al. 1993; Mayer et al. 2018) . Amphetamineinduced DA release was significantly smaller in the SNc compared to previous FSCV measurements of amphetamineinduced release in the striatal slices (Jones et al. 1998; Schmitz et al. 2001 ). However, it should be noted that long-duration FSCV recordings are prone to background drift, which has comparatively little effect on FSCAV. Additionally, larger amphetamine-induced DA release is consistent with a larger releasable pool of DA and higher expression of DAT in the striatum compared to the SNc (Hoffman et al. 1998) . Importantly, our FSCAV recordings of amphetamine-induced DA release were comparable to chrono-amperometry measurements in the SNc .
Basal [DA] out was also enhanced by cocaine, confirming that DAT inhibition promotes extracellular accumulation of DA (Fortin et al. 2006; Mendez et al. 2011) . In addition, exogenous L-DOPA also increased [DA] out by enhancing DA production and release (Gantz et al. 2013) . Conversely, depletion of vesicular DA stores by Ro4-1284 decreased basal [DA] out , consistent with the ability of reserpine to decrease tissue levels of DA (Heeringa and Abercrombie 1995) . Finally, inhibition of DA metabolism with pargyline had no effect on basal [DA] out , indicating that 3,4-dihydroxyphenylacetic acid did not contribute to FSCAV recordings and/or basal MAO activity in brain slices is low (Fig. 3d) . However, even though pargyline (10 lM) significantly increased [DA] out after L-DOPA exposure (L-DOPA + pargyline vs. L-DOPA alone; data not shown), a higher concentration of pargyline (up to 100 lM) has been shown to inhibit spontaneous firing of SNc neurons (Mercuri et al. 1996) . This suggests that a higher dose or longer exposure to pargyline may have been required to demonstrate a role of MAO in regulating basal [DA] out .
FSCAV measurements indicated that basal [DA] out was considerably higher in vivo than in brain slices. Basal [DA] out in the SNc of urethane-anesthetized rats was approximately 80 nM, suggesting that tonic release is greater in vivo, or that a substantial amount of DA is 'washed out' in brain slices. Greater DA release in animals maintained 2°C warmer than brain slices is consistent with temperature-dependence of spontaneous release (Jaffe et al. 1998) . Furthermore, tonic activity of intact synaptic inputs may enhance somatodendritic DA release in vivo (Rosales et al. 1994; Cobb and Abercrombie 2003) . This difference between basal [DA] out in vivo and in brain slices is indirectly supported by the larger effect of D 2 receptor antagonists on SNc neuron firing in vivo (Bunney et al. 1973) compared to brain slices (Werkman et al. 2001; Guatteo et al. 2013) , suggesting there is larger tonic auto-inhibition by a higher basal [DA] out in vivo.
Basal [DA] out in anesthetized rats has previously been estimated in the SNc by microdialysis, indicating that extracellular DA levels are in the low/sub-nanomolar range (Hoffman et al. 1997; Bergquist et al. 2002; Sarre et al. 2004) , considerably lower than our FSCAV recordings. This discrepancy may reflect an inability of relatively large microdialysis probes (diameter > 250 lm) to accurately sample from small brain structures like the SNc, particularly since probe implantation can cause tissue damage, forming an additional diffusion barrier for DA (Bungay et al. 2003) . Thus, previous microdialysis studies have likely underestimated basal [DA] out in the SNc. Consistent with this notion, microdialysis measurements of basal [DA] out in the mouse nucleus accumbens (Frank et al. 2008) are considerably lower than in vivo FSCAV recordings in the same region .
Amphetamine-induced DA release measured with FSCAV in vivo was larger than previous microdialysis studies following systemic injection of the same dose of the drug (Robertson et al. 1991; Heeringa and Abercrombie 1995) . However, FSCAV recordings were comparable to microdialysis measurements after a significantly higher concentration of amphetamine (250 lM) was applied through the microdialysis probe (Hoffman et al. 1997) . This supports the idea that FSCAV provides higher sensitivity for measuring [DA] out than microdialysis.
Mechanisms of tonic somatodendritic DA release Importantly, the present study provides additional evidence that tonic somatodendritic DA release is largely independent of action potentials. While electrically stimulated DA release is abolished by TTX Beckstead et al. 2004) , our data showed that inhibition of voltage-gated Na + channels decreased basal [DA] out by less than 10%, despite complete inhibition of neuronal firing. Even when firing rate and DA production were enhanced by L-DOPA and raclopride, TTX had little effect on [DA] out . This fundamental difference between spontaneous and stimulated somatodendritic DA release indicates that these processes are regulated by different mechanisms.
Previous studies have also reported that spontaneous somatodendritic DA release can be independent of action potential firing (for refs. see Introduction). Interestingly, the frequency of amperometric events and D 2 -IPSCs mediated by spontaneous DA release (< 0.1 Hz), is significantly lower than the firing rate of SNc neurons (2-5 Hz), indicating that quantal DA release is not directly associated with action potentials (Jaffe et al. 1998; Kim et al. 2008; Gantz et al. 2013) . This is consistent with our observation that basal [DA] out was not correlated with spontaneous firing frequency of SNc neurons, although it should be noted that single-unit firing does not necessarily reflect the firing rate of all SNc neurons in the vicinity of the CFM. In contrast, changing [Ca 2+ ] out evoked opposite effects on [DA] out and neuronal firing rate, demonstrating the dissociation between firing and release. Previous measurements of somatodendritic DA release by radioassay also indicate that inhibition of voltage-gated Na + channels does not completely abolish spontaneous DA release (Fortin et al. 2006; Mendez et al. 2011) . Finally, local infusion of TTX in vivo reduces microdialysis measurements of nigral [DA] out by only 60% (Sarre et al. 2004 ). In agreement with these studies, our data indicate that a significant component of tonic somatodendritic DA release is not dependent on action potentials.
Action potential-independent mechanisms of somatodendritic DA release may involve reverse transport via DAT (Elverfors et al. 1997; Falkenburger et al. 2001) . However, our data demonstrated that tonic DA release does not involve reverse transport, since DAT inhibition increased (rather than decreased) basal [DA] out . This is consistent with the ability of DAT blockers to potentiate both spontaneous (Fortin et al. 2006; Mendez et al. 2011) and stimulated somatodendritic DA release Beckstead et al. 2004) .
Conversely, inhibition of VMAT2 decreased basal [DA] out , indicating that releasable stores of DA (vesicular or endoplasmic reticulum, since both express VMAT2 in the SNc; Nirenberg et al. 1996) are required for tonic release. This is consistent with the effect of reserpine on spontaneous somatodendritic DA release (Heeringa and Abercrombie 1995; Gantz et al. 2013) , and suggests that release involves an exocytosis-like mechanism. Indeed, exocytotic machinery including SNARE and synaptotagmin proteins are required for tonic DA release (Fortin et al. 2006; Mendez et al. 2011) . However, the sensitivity of somatodendritic release to botulinum toxins differs to that of DA exocytosis from axon terminals, supporting different mechanisms of release between these regions (Bergquist et al. 2002) . This is consistent with expression of unusual syntaxin, SNAP and synaptobrevin isoforms , and higher affinity Ca 2+ sensors (synaptotagmin 4 and 7) in the somatodendritic compartment of SNc neurons (Mendez et al. 2011 (Guatteo et al. 2013) , supporting membrane potential regulation of spontaneous somatodendritic DA release. Notably, D 2 receptors are highly expressed on dendrites of SNc neurons (Yung et al. 1995) , as well as in subcellular DA storage sites (saccules of smooth endoplasmic reticulum; Sesack et al. 1994 (Guzman et al. 2009 ), since the low dose of isradipine required to decrease [DA] out has no effect on somatic [Ca 2+ ] in (Ortner et al. 2017) . Involvement of L-type Ca 2+ channels is consistent with dependence of quantal DA release on these channels (Kim et al. 2008) . However, spontaneous D 2 -IPSCs are not dependent on voltage-gated Ca 2+ channels (Gantz et al. 2013) , while DA radioassay indicates that N-and P/Q-, but not L-type channels are required for tonic release (Mendez et al. 2011) . In contrast, electrically evoked D 2 -IPSCs are dependent on N-, but not L-type Ca 2+ channels (Beckstead et al. 2004) , while stimulated DA spillover shows limited dependence on voltage-gated Ca 2+ channels (Chen et al. 2006) but is regulated by intracellular Ca 2+ stores (Bunney et al. 1973; Werkman et al. 2001; Guatteo et al. 2013) . More importantly, tonic somatodendritic DA release regulates basal ganglia output by activating presynaptic D 1 receptors on striatonigral or pallidonigral afferents (Windels and Kiyatkin 2006) . In this way, basal [DA] out may set the gain of basal ganglia output (Yin 2016) . In addition to involvement in motor control (Crocker 1997; Trevitt et al. 2001) , somatodendritic DA release has important functions for both development (Cragg et al. 1998 ) and synaptic plasticity in mature neurons (Prescott et al. 2009 ). Spontaneous neurotransmitter release can regulate dendritic protein translation (Sutton et al. 2007 ) and plays an important role in neuronal homeostasis (Kavalali 2015) .
Furthermore, somatodendritic DA release affects expression of brain-derived neurotrophic factor (Bustos et al. 2004) , which may influence survival of SNc neurons (Hyman et al. 1991) . Conversely, Ca v 1.3 channel activity and readily oxidized extracellular DA may contribute to high vulnerability of SNc neurons to damage (Hastings et al. 1996; Guzman et al. 2010) . Our data show that Ca v 1.3 channel inhibition decreases [DA] out without modifying electrophysiological activity of SNc neurons, supporting the potential of isradipine for treatment of Parkinson's disease (Simuni and Group 2013; Surmeier et al. 2017) .
Typically the relationship between [Ca 2+ ] in and evoked transmitter release is supralinear, producing an 'all or nothing' response following sufficient Ca 2+ influx (Ramirez and Kavalali 2011) . In contrast, spontaneous somatodendritic DA release is largely action potential-independent, and responds to [Ca 2+ ] out over a smaller range than axonal release (Chen and Rice 2001) . This near-linear Ca 2+ -dependence allows tonic DA release to be graded by afferent inputs, promoting highly sensitive somatodendritic output with accurate temporal fidelity. A similar mode of tonic neurotransmitter release, graded by small changes of membrane potential (in the absence of action potentials), occurs from photoreceptors at ribbon synapses in the retina (Heidelberger 2007) . Indeed, SNc neurons express similar SNARE proteins as photoreceptor cells (Curtis et al. 2008; Rice and Patel 2015) . Furthermore, Ca v 1.3 L-type Ca 2+ channels may contribute to an equivalent 'dark current' in SNc neurons, which facilitates action potential-independent, spontaneous somatodendritic DA release. While this concept remains to be confirmed, the idea of a 'dark' current is fitting for aptly named neurons of the 'Substantia Nigra'.
